← Back to Analyst Consensus 
JSPR Buy
Jasper Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 12, 2026 | Piper Sandler | initiate | — → Overweight | — | 54% |
| May 15, 2026 | TD Cowen | downgrade | Buy → Hold | — | 54% |
| May 15, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Apr 1, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Nov 11, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $4 | 55% |
| Sep 22, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $14 | 58% |
| Sep 22, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $6 | 53% |
| Sep 22, 2025 | BTIG | maintain | Buy → Buy | $7 | 52% |
| Aug 15, 2025 | UBS | maintain | Buy → Buy | $25 | 54% |
| Jul 8, 2025 | BMO Capital | downgrade | Outperform → Market Perform | $4 | 53% |
| Jul 8, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $12 | 53% |
| Jul 8, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $20 | 58% |
| Jul 7, 2025 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Jul 7, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $20 | 44% |
| Jul 7, 2025 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $0 | 50% |
| Jul 7, 2025 | BTIG | maintain | Buy → Buy | $20 | 52% |
| May 15, 2025 | Oppenheimer | maintain | Outperform → Outperform | $65 | 52% |
| May 13, 2025 | UBS | maintain | Buy → Buy | $33 | 54% |
| Mar 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Feb 13, 2025 | UBS | initiate | — → Buy | $38 | 54% |
| Jan 10, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $70 | 53% |
| Jan 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $40 | 44% |
| Jan 9, 2025 | RBC Capital | maintain | Outperform → Outperform | $48 | 55% |
| Jan 6, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $70 | 53% |
| Dec 23, 2024 | RBC Capital | reiterate | Outperform → Outperform | $68 | 55% |
| Dec 6, 2024 | BMO Capital | initiate | — → Outperform | $63 | 53% |
| Oct 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $65 | 44% |
| Oct 15, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $70 | 53% |
| Oct 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $65 | 44% |
| Sep 27, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $70 | 53% |
| Sep 9, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Sep 9, 2024 | JMP Securities | initiate | — → Market Outperform | $70 | 53% |
| Aug 26, 2024 | Evercore ISI Group | maintain | Outperform → Outperform | $65 | 58% |
| Aug 14, 2024 | RBC Capital | maintain | Outperform → Outperform | $68 | 55% |
| Aug 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $65 | 44% |
| Aug 5, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $65 | 44% |
| Jul 8, 2024 | BTIG | initiate | — → Buy | $90 | 52% |
| Jun 27, 2024 | Stifel | initiate | — → Buy | $86 | 53% |
| Jun 18, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| May 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $65 | 44% |
| May 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $65 | 44% |
| May 6, 2024 | HC Wainwright & Co. | initiate | — → Buy | $65 | 44% |
| Apr 3, 2024 | Evercore ISI Group | initiate | — → Outperform | $65 | 58% |
| Mar 28, 2024 | RBC Capital | initiate | — → Outperform | $70 | 55% |
| Mar 18, 2024 | TD Cowen | initiate | — → Outperform | $0 | 54% |
| Mar 7, 2024 | Oppenheimer | maintain | Outperform → Outperform | $80 | 52% |
Price Target Trend
Jun 21, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days